ALLO
Allogene Therapeutics Inc
1.50$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 66.5% | 71.4% | 67.4% | 70.7% | 51.7% | 55.3% | 57.4% | 60.1% | 59.3% | 62.0% | 69.0% | 61.8% | |
| 9.7% | 12.9% | 8.7% | 26.4% | 8.7% | 13.7% | 8.4% | 11.1% | 8.6% | 12.4% | 7.7% | 7.0% | |
| 65.3% | 69.8% | 65.6% | 68.7% | 49.5% | 53.3% | 55.1% | 58.0% | 57.3% | 60.2% | 67.4% | 60.5% | |
| 0.2% | 0.3% | 0.3% | 0.3% | 0.5% | 0.3% | 0.5% | 0.4% | 0.5% | 0.4% | 0.3% | – | |
| -0.2% | -0.3% | – | – | – | – | – | – | – | – | – | – | |
| 18.1% | 20.3% | 21.3% | 20.4% | 21.3% | 23.1% | 24.1% | 26.8% | 28.3% | 29.7% | 29.6% | 20.7% | |
| 5.3% | 5.8% | 5.3% | 5.8% | 5.5% | 6.5% | 5.9% | 6.7% | 7.2% | 7.8% | 7.2% | 5.8% | |
| 0.9% | 1.1% | 1.2% | 1.1% | 1.3% | 1.4% | 1.5% | 1.6% | 1.8% | 2.0% | 2.1% | – | |
| 0.9% | 0.9% | 1.0% | 2.0% | 0.9% | 1.0% | 1.0% | 1.0% | 0.8% | 1.0% | 1.2% | 1.1% | |
| 81.9% | 79.7% | 78.7% | 79.6% | 78.7% | 76.9% | 75.9% | 73.2% | 71.7% | 70.3% | 70.4% | 79.3% | |
| -206.9% | -243.0% | -277.5% | -261.8% | -298.7% | -331.7% | -370.0% | -410.2% | -448.4% | -483.5% | -518.6% | -381.0% | |
| 23.5% | 26.2% | 28.8% | 29.4% | 35.5% | 38.4% | 42.4% | 46.5% | 50.5% | 53.0% | 60.7% | 59.8% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.